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a b s t r a c t
The synthesis of chiral-centered selenium compounds is presented. Enantioselective oxidations of these
organoselenium compounds were performed using a wide range of biocatalysts, including
BaeyereVilliger monooxygenases, oxidoreductases-containing Aspergillus terreus and lipase (Cal-B) in
the presence of oxidants. Finally, efﬁcient synthesis of enantiopure organoselenium compounds using
a kinetic resolution approach mediated by Cal-B was achieved.
 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Organoselenium compounds are very useful in organic synthe-
sis, and they are regularly employed in the preparation of many
organic compounds including natural products.1 They can be used
in nucleophilic, electrophilic, and radical reactions due to their
chemical properties and can be incorporated into a variety of sub-
strates under mild conditions.2 Additionally, organoselenium
compounds have shown biological activities like antioxidant, anti-
tumor, antimicrobial, and antiviral activities.3 Including these
activities, we can mention that chiral and achiral organoselenanes
can inactivate protein tyrosine phosphatases (PTPs)4 and cysteine
proteases5 (cathepsins S and V) thereby acting as enzyme inhibitors.
The b-elimination reaction is the best-known reaction of selenium
compounds, which involves selenoxides with a b-hydrogen atom.
This reaction has been used as an efﬁcient synthetic tool to prepare
alkenes and a,b-unsaturated ketones.6 Selenoxides are generally
prepared from the corresponding selenides using common oxidants
like hydrogen peroxide and sodium metaperiodate.6
Besides being interesting synthetic intermediates, chiral orga-
noselenium compounds have been satisfactorily used as catalysts
or chiral ligands in organic transformations such as hydrosilylation
of enamines and ketones, enantioselective addition of dio-
rganozinc to aldehydes and enantioselective conjugate addition of
organometallic to enones.2 Indeed, asymmetric synthesis using
organochalcogen compounds in general is of current interest in the
ﬁeld of organometallic chemistry.7 Despite the great usefulness of
chiral selenides, the asymmetric synthesis of optically active
organoselenium compounds is still a challenge in selenium
chemistry.8
Very few studies on the enzymatic reactions of selenium com-
pounds for synthetic purposes have been published to date.9 En-
zymatic processes, due to their wide applications under mild
conditions, are environmentally friendly reactions. From the syn-
thetic organic point of view the enzyme-catalyzed reactions pres-
ent a vast opportunity to selenium chemistry regarding selectivity,
including regio-, enantio-, and chemoselectivity.
In the search for novel chiral-centered selenium compounds to
be used in our studies for the development of protease inhibitors,4,5
we encountered a lack of synthetic methodologies to obtain such
compounds. We here describe a study about the application of
different chemoenzymatic approaches to obtain chiral-centered
selenium compounds, see Fig. 1. An oxidative approach was applied
to racemic organoselenium compounds in order to perform their
kinetic resolution in enzyme-mediated reactions (Fig. 1a). The
second approach involved kinetic resolution of precursor 1-
phenylethanols by lipases, and their transformation to the desired
chiral organoselenium compounds using selenium chemistry
(Fig. 1b).
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2. Results and discussion
2.1. Synthesis of chiral-centered selenium compounds: kinetic
resolution using a selenium oxidation approach
Initially, we synthesized phenylselenium derivatives (1e3) in
which the selenium atom is attached to a phenyl and a 1-
phenylethyl group. The protocol was based on the inversion of
conﬁguration of the phenylethanol derivatives by their reactions
with phenylselenocyanide and tributylphosphine (Scheme 1).10
Next, we performed the synthesis of benzylselenides derivatives
(4e6). Initially, mesylated phenylethanol derivatives were pre-
pared in situ from their corresponding alcohols and mesyl chloride
(MsCl). Then, benzyl selenoate was prepared from benzyl bromide
(BnBr), elemental selenium, and NaBH4, which was then trans-
ferred to the mesylated derivatives to give the benzylselenides
(4e6) (Scheme 1).11 It is noteworthy that the addition of DMF is
relevant for the success of the reaction. In fact, DMF improves the
yield by solubilizing the selenolate anion, which is otherwise
known to exist as boron complex possessing diminished
nucleophilicity.11
2.1.1. Oxidative kinetic resolution of chiral selenides mediated by
BVMOs. BaeyereVilliger monooxygenases (BVMOs) are ﬂavin-
containing and NAD(P)H-dependent enzymes that catalyze the
incorporation of one oxygen atom into organic substrates.12 BVMOs
usually mediate reactions with high enantio- and/or regiose-
lectivity13 and they are known to be excellent alternatives for
performing the oxidation of aldehydes and ketones to their corre-
sponding esters, the oxygenation of heteroatoms (sulfur, nitrogen,
phosphorus, boron, and selenium) and even epoxidation
reactions.9c,14
For the selenium oxidation approach using BVMOs, we ﬁrst
selected the phenylselenide derivative 1 as model substrate and
PAMO as biocatalyst. This compound was selected to evaluate the
inﬂuence of a phenyl group directly attached to the selenium
atom on the oxidation reaction. We also employed a cofactor
regenerating system with phosphite dehydrogenase (PTDH) and
a sacriﬁcial substrate (sodium phosphite). In this test we observed
that the oxidation reaction occurred with good enantioselectivity
(84% ee, Table 1, entry 1). Next, we increased the amount of
phosphite in the reaction medium leading to higher enantiose-
lectivity (98% ee, Table 1, entry 2). By applying the same reaction
conditions to compound 4 (with the benzyl group attached to the
selenium atom and no substituent in the aromatic ring) lower
enantioselectivity was observed (14% ee, Table 1, entries 6 and 7).
As hydrogen peroxide can be produced by BVMOs, we also eval-
uated the use of catalase, an enzyme that degrades hydrogen
peroxide into dioxygen and water. However, we observed several
by-products even with no PAMO in the reaction medium (control
reactions). These results could be due to the low purity of com-
mercial catalase that can contain small quantities of other
oxidoreductases.
In an effort to investigate other BVMOs, we performed reactions
using M446G PAMO, CHMO, and HAPMO as biocatalysts. When
M446G PAMO mediated the reactions, good conversions but low
enantioselectivity were observed (Table 1, entries 3 and 8). When
CHMOor HAPMOwas employed, no reactionwas observed (Table 1,
entries 4, 5, 9, and 10).
By using appropriate reaction condition with PAMO, we de-
cided to explore the oxidative kinetic resolution of several
other selenides (2, 3, 5, and 6, Table 1, entries 11e14). In all cases,
the selenium oxidation was observed but with low or no
enantioselectivity.
In an ideal oxidative kinetic resolution of selenides, a b-elimi-
nation reaction should be observed with one enantiomer, which
would produce RSeOH and styrene derivative (RCH]CH2), and the
other enantiomerwould be untouched. After assigning the absolute
conﬁguration we concluded that, when the selenium oxidation
occurs, the (R)-selenide undergoes the oxidation faster than the (S)-
selenide.
2.1.2. Oxidative kinetic resolution of (RS)-phenylselenide 1 mediated
by Aspergillus terreus. We have recently described that A. terreus
Fig. 1. Chemoenzymatic approaches to obtain chiral-centered selenium compounds.
Scheme 1. Synthesis of selenides 1e6: (a) PhSeCN, Bu3P, toluene, 20 h, rt (b) DMAP, CH2Cl2, MsCl, 16 h, rt (c) NaBH4, EtOH/DMF, 3 h, rt.
P.B. Brondani et al. / Tetrahedron 68 (2012) 10431e1043610432
strains (URM 3571 and CCT 3320) produce oxidoreductases,
which can mediate BaeyereViliger reactions, deracemization of
several phenylethanol derivatives, and selenium oxidations.9d,15
We tested these fungal strains for the oxidation of the phe-
nylselenide derivative 1, which was the best substrate in the pre-
vious reactions with BVMOs. The reactions were carried out using
buffer, substrate, and fungal cells, which were incubated at 32 C
for 1, 3, and 5 days. All bio-oxidations were followed by a control
reaction in the absence of fungal cells. However, even in 5 days, the
phenylselenide 1 remained in the racemic form. This lack of re-
activity can be attributed to the presence of a steric hindrance near
to the selenium atom. As (RS)-phenylselenide 1 has two bulky
moieties surrounding the selenium atom, it can be hindering the
oxidation mediated by enzymes from A. terreus. In a previous study
with fungi and organoselenium alcohols, we observed a similar
result, in which selenium oxidation is very slow or does not occur
at all.9d
2.1.3. Oxidative kinetic resolution of (RS)-phenylselenide 1 mediated
by Candida antarctica lipase B (CAL-B) in the presence of oxi-
dants. Lipases are also known to catalyze oxidations when in the
presence of oxidizing species such as H2O2 or peracids, which
constitutes an alternative method for bio-oxidations. They can be
used in epoxidation reactions or, by lipase-mediated in situ for-
mation of peroxy acids, even in BaeyereVilliger reactions.16 Among
the lipases studied so far, Novozym 435, a commercial preparation
of lipase from C. antarctica, has been shown the best results in
oxidative transformations becoming the most popular lipase for
this purpose.16
In this context, we decided to explore the use of lipase in the
presence of oxidants (H2O2, NaIO4, m-CPBA) in order to perform
enantioselective oxidation of organoselenium compounds. There-
fore, the lipase-induced enantioselective oxidation reactions were
carried out at 0 C and room temperature in organic solvent. Con-
trol reactions in the absence of lipase and/or oxidant were also
studied (Table 2).
In most cases, no enantioselectivity (Table 2, entries 1, 2, 7, 9, 10,
and 11) or no reaction was observed (Table 2, entries 3 and 6). In
control reactions, we observed oxidation reaction without lipase,
which can be the reason for the low enantioselectivity. However,
the best system used was m-CPBA in n-hexane at room tempera-
ture (Table 2, entry 8), which resulted in enantioselective oxidation
of (R)-1. In fact, these results demonstrate the potential of peracids
and lipase for enantioselective selenium oxidation, without pre-
cedent until now.
Table 2
Oxidative kinetic resolution of compound (RS)-1 mediated by CAL-Ba
Entry Oxidant Solvent Temperature
(C)
Time
(h)
Conv.b
(%)
eec
(S)-1 (%)
1 H2O2 Hexane 0 2 90 (d)e
2 H2O2f Hexane 25 0.5 100 (d)e
3 NaIO4 Hexane 0 2 (d)d (d)e
4 NaIO4 Hexane/MeOH (9:1) 25 2 5 7
5 NaIO4 Hexane/MeOH (1:1) 25 2 3 (d)e
6 NaIO4 Hexane/EtOAc (9:1) 25 2 (d)d (d)e
7 NaIO4 Hexane/MeOH (9:1) 25 15 52 7
8 m-CPBA Hexane 25 2 46 45
9 m-CPBA Hexane/MeOH (9:1) 25 2 100 (d)e
10 m-CPBA Hexane/EtOAc (9:1) 25 2 90 5
11 m-CPBA Toluene 25 2 100 (d)e
a Substrate (0.25 mM), solvent (1 mL), CAL-B (20 mg), oxidant (3 equiv), 0 or
25 C, 2e15 h.
b Conv.¼conversion based on selenide consumption using HPLC analysis.
c Enantiomeric excess measured by HPLC.
d No reaction was observed.
e No ee was observed.
f 2 equiv.
Table 1
Oxidative kinetic resolution of selenium-containing aromatic compounds 1e6 mediated by BVMOsa
Entry Substrate BVMO Phosphite (mM) Time (h) Conv.b (%) eec (%)
1 1 PAMO 20 5 52 84
2 1 PAMO 50 5 49 98
3 1 M446G 50 5 45 10
4 1 HAPMO 50 24 (d)d (d)e
5 1 CHMO 50 24 (d)d (d)e
6 4 PAMO 20 5 53 (d)e
7 4 PAMO 50 5 56 14
8 4 M446G 50 5 51 10
9 4 HAPMO 50 24 (d)d (d)e
10 4 CHMO 50 24 (d)d (d)e
11 2 PAMO 50 8 51 9
12 3 PAMO 50 8 54 (d)e
13 5 PAMO 50 5 49 (d)e
14 6 PAMO 50 5 47 49
a Tris buffer 50 mM pH 7.5, DMSO (1%), substrate (10 mM), phosphite (20 or 50 mM), PTDH (1 mM), NADPH (0.2 mM), and BVMO (8 mM).
b Conv.¼conversion based on selenide consumption using HPLC analysis.
c Enantiomeric excess measured by HPLC.
d No reaction was observed.
e No ee was observed.
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2.2. Synthesis of chiral-centered selenium compounds: ki-
netic resolution using a transesteriﬁcation approach
Another approach was evaluated to obtain both enantiomers of
chiral selenides 1e6. Kinetic resolution of phenylethanol derivatives
through a lipase-catalyzed transesteriﬁcation reaction was the pro-
tocol of choice. This processwas performedwith vinyl acetate as acyl
donor and Cal-B as biocatalyst (Scheme 2).17 We obtained the corre-
sponding (R)-acetate and the untouched (S)-alcohol in high ee,>99%.
After column chromatography and ester hydrolysis, both enan-
tiomerically pure phenylethanol derivatives were achieved. Then,
these alcohols were transformed into the chiral selenides 1e6 using
the same protocol described in the Section 2.1. As the insertion of
the selenium moiety involved a Mitsunobu reaction or a nucleo-
philic substitution reaction with a selenolate species, we noticed
that an (S)-alcohol will provide an (R)-selenide while an (R)-alcohol
will provide an (S)-selenide.
3. Conclusion
Among the BVMOs tested, PAMO showed the best results for ox-
idation of chiral selenides. PAMO was able to oxidize
phenylselenium-containing compound with no substituent in the
aromatic ring with great enantioselectivity (98% ee). The mutant
M446Gshowedasimilar substrateacceptance,but it displayed lower
enantioselectivity. The BVMOs, HAPMO, and CHMOwere not able to
oxidize any of the tested substrates. When whole cells of A. terreus
were used, no signiﬁcant selenium oxidationwas observed. By using
another approach, Cal-B in the presence of m-CPBA as oxidant spe-
cies, enantioselective conversionwas observed (45% ee). By applying
a different approach, lipase-catalyzed transesteriﬁcation reactions
provided us the enantiomerically pure alcohols, which were trans-
formed into the desired chiral benzyl and phenylselenides.
4. Experimental
4.1. General
Recombinant phenylacetone monooxygenase (PAMO) from
Thermobiﬁda fusca, M446G PAMO mutant, 4-hydroxyaceto-
phenone monooxygenase (HAPMO) from Pseudomonas ﬂuo-
rescens, and cyclohexanone monooxygenase (CHMO) from Aci-
netobacter sp. were overexpressed and puriﬁed as previously
described.18 Phosphite dehydrogenase was obtained as previously
described.19 Both sodium phosphite and NADPH were purchased
from SigmaeAldrich. Gas chromatography (GC) analyses were
performed on a Shimadzu GC-17A instrument equipped with
a ﬂame ionization detector. High performance liquid chroma-
tography (HPLC) analyses were performed on a Shimadzu LC-
10AD or Shimadzu SPD-M1OA liquid chromatograph equipped
with a variable wavelength UV detector (deuterium lamp
190e600 nm). Sterile materials were used to perform the ex-
periments involving microorganisms. A laminar ﬂow cabinet
Fisher Hamilton (Class II Biological Safety Cabinet) was used to
handle microorganisms.
4.2. General procedure for synthesis of chiral organoselenium
compounds (1e3)
The enantiomerically pure forms of 1-phenylethanols de-
rivatives were prepared by lipase-catalyzed transesteriﬁcation re-
actions of their racemic forms with vinyl acetate according to the
methodology described in literature.17 Each enantiomer of organo-
selenium compounds (1e3) was synthesized from 1-phenylethanol
derivatives by their reactions with phenylselenocyanide and tribu-
tylphosphine as described in literature.10
4.2.1. Phenyl(1-phenylethyl)selane (1). Yellow oil (82%), 1H NMR
(200 MHz, CDCl3): d 1.73 (d, J¼7.0 Hz, 3H), 4.43 (q, J¼7.0 Hz),
7.20e7.60 (m, 10H). 13C NMR (50 MHz, CDCl3): d 22.1, 42.4, 127.1,
127.7, 128.3, 128.8, 129.1, 131.4, 135.4,141.6, 143.5. LRMS (EI)m/z (%):
262 (Mþ, 5), 156 (8), 105 (100), 79 (10), 78 (9), 77 (14), 51 (7). FT-IR
(ﬁlm, cm1) nmax: 3057, 2961, 2918, 1576, 1474, 1436, 1021, 762, 691,
467. [a]D2270 (c 1.0, CH2Cl2) for (S)-enantiomer (ee>99%) and [a]D22
þ87 (c 1.0, CH2Cl2) for (R)-enantiomer (ee>99%).
The enantiomeric excess was analyzed by HPLC equipped with
a Chiracel OJ-H column. Eluent¼mixture of n-heptane and iso-
propanol or n-hexane and iso-propanol (99:1). Flow rate¼0.5 mL/
min; UV detector¼254 nm; retention times: tR¼21.55 min (S) and
31.88 min (R) or tR¼16.01 min (S) and 31.13 min (R).
Scheme 2. Synthesis of enantiopure chiral selenides 1e6: (a) Cal-B, vinyl acetate, n-hexane, 32 C, 160 rpm, 24 h; (b) PhSeCN, Bu3P, THF, 16 h, rt; (c) DMAP, MsCl, CH2Cl2, 16 h, rt; (d)
[BnSe] prepared from elemental selenium, NaBH4, benzyl bromide, EtOH/DMF, 3 h rt; (e) NaOH 1 M, MeOH, 1 h.
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4.2.2. Phenyl-[1-(4-tolylethyl)]selane (2). Yellow oil (87%), 1H NMR
(200 MHz, CDCl3): d 1.73 (d, J¼7.0 Hz, 3H), 2.30 (s, 3H), 4.44 (q,
J¼7 Hz, 1H), 7.04e7.63 (m, 9H). 13C NMR (50 MHz, CDCl3): d 21.1,
22.3, 42.2, 127.0, 127.7, 129.1, 131.4, 135.2,136.6, 140.5. LRMS (EI)m/z
(%): 276 (Mþ, 4), 156 (6), 119 (100), 91 (20), 77 (12), 65 (5), 51 (4). FT-
IR (ﬁlm, cm1) nmax: 3054, 2961, 2919, 1576, 1511, 1474, 1437, 1020,
816, 736, 689, 532, 466. [a]D22 151 (c 1.0, CH2Cl2) for (S)-enantio-
mer (ee>99%) and [a]D22 þ130 (c 1.0, CH2Cl2) for (R)-enantiomer
(ee>99%).
The enantiomeric excess was analyzed by HPLC equipped with
a Chiracel OJ-H column. Eluent¼n-heptane. Flow rate¼0.5 mL/
min; UV detector¼220 nm; retention times: tR¼37.74 min (S) and
41.54 min (R).
4.2.3. 1-(4-Fluorophenyl)ethyl-phenylselane (3). Yellow oil (79%),
1H NMR (200 MHz, CDCl3): d 1.72 (d, J¼7.2 Hz, 3H), 4.43 (q,
J¼7.2 Hz, 1H), 6.80e6.96 (m, 2H), 7.14e7.28 (m, 5H), 7.38e7.43 (m,
2H). 13C NMR (50 MHz, CDCl3): d 22.2, 41.6, 114.8, 115.2, 127.9,
128.6, 128.8, 128.8, 135.6, 161.6 (d, J¼244 Hz). LRMS (EI) m/z (%):
280 (Mþ, 6), 262 (4), 105 (100), 91 (41), 77 (9), 65 (7), 51 (4). FT-IR
(ﬁlm, cm1) nmax: 3070, 2965, 2864, 1602, 1508, 1223, 834, 741,
692, 533, 469. [a]D22 180 (c 1.0, CH2Cl2) for (S)-enantiomer
(ee>99%) and [a]D22 þ168 (c 1.0, CH2Cl2) for (R)-enantiomer
(ee>99%).
The enantiomeric excess was analyzed by HPLC equipped with
a Chiracel OJ-H column. Eluent¼n-heptane. Flow rate¼0.5 mL/
min; UV detector¼254 nm; retention times: tR¼27.88 min (S) and
32.61 min (R).
4.3. General procedure for synthesis of chiral organoselenium
compounds (4e6)11
To a 50 mL round-bottomed ﬂask (I) were added the enantio-
merically pure forms of phenylethanol derivative (1 mmol, pre-
pared as described in Section 4.2), CH2Cl2 (50 mL), and DMAP
(2 mmol, 0.244 g). After 15 min, MsCl (1.5 mmol, 0.12 mL) was
added slowly. The reaction mixture was stirred overnight at room
temperature.
In a second 50 mL round-bottomed ﬂask (II) were added sele-
nium (1 mmol, 0.080 g), EtOH (3 mL), DMF (2 mL), and NaBH4
(1 mmol, 0.037 g). The mixture was stirred for 15 min and then
BnBr (1 mmol, 0.119 mL) was added. After stirring 3 h at room
temperature, additional amount of NaBH4 (1.5 mmol, 0.055 g) was
added. The reaction mixture was stirred over more 20 min. The
content of ﬂask (I) was added slowly to the ﬂask (II) and the
resulting mixture was stirred at room temperature for 3 h.
After that, the ethanol/DMF was removed in vacuum, and
H2O (5 mL) was added into the crude material. The resulting
aqueous mixture was extracted with Et2O (25 mL) and the
organic extract was dried over MgSO4. The solvent was removed
in vacuum and the mixture was puriﬁed by ﬂash column chro-
matography (pentane as eluent) providing the pure product
(50e75% yield).
4.3.1. Benzyl-(1-phenylethyl)selane (4). Yellow oil (65%), 1H NMR
(200 MHz, CDCl3): d 1.69 (d, J¼7.0 Hz, 3H), 3.70 (s, 2H), 4.07 (q,
J¼7.0 Hz, 1H), 7.19e7.28 (m, 10H). 13C NMR (50 MHz, CDCl3): d 22.5,
37.7, 53.0, 126.6, 127.3, 128.3, 128.8, 139.0, 144.1. LRMS (EI) m/z (%):
276 (Mþ, 6), 262 (4), 105 (100), 91 (41), 77 (9), 65 (7), 51 (4). FT-IR
(ﬁlm, cm1) nmax: 3026, 2920, 1493, 1452, 1177, 760, 695, 608, 478.
[a]D22þ30 (c 1.0, CH2Cl2) for (S)-enantiomer (ee>99%) and [a]D2245
(c 1.0, CH2Cl2) for (R)-enantiomer (ee>99%).
The enantiomeric excess was analyzed by HPLC equipped with
a Chiracel OJ-H column. Eluent¼mixture of n-heptane and iso-
propanol (99:1). Flow rate¼0.8 mL/min; UV detector¼254 nm; re-
tention times: tR¼22.75 min (S) and 26.88 min (R).
4.3.2. Benzyl-[1-(4-tolylethyl)]selane (5). Yellow oil (50%), 1H NMR
(200 MHz, CDCl3): d 1.69 (d, J¼7.0 Hz, 3H), 2.31 (s, 3H), 3.80 (s, 2H),
3.99 (q, J¼7.0 Hz, 1H), 7.12e7.25 (m, 9H). 13C NMR (50 MHz, CDCl3):
d 21.1, 32.5, 41.0, 52.9, 127.1, 128.3, 128.9, 128.9, 137.0, 139.1, 140.0,
144.8. LRMS (EI) m/z (%): 290 (Mþ, 3), 207 (4), 182 (3), 120 (12), 119
(100), 118 (13), 117 (14), 91 (55), 77 (8), 65 (10), 51 (6). FT-IR
(ﬁlm, cm1) nmax: 3024, 2917, 1655, 1510, 1440, 1029, 816, 757,
695, 591, 492. [a]D22þ63 (c 1.0, CH2Cl2) for (S)-enantiomer (ee>99%)
and [a]D22 76 (c 1.0, CH2Cl2) for (R)-enantiomer (ee>99%).
The enantiomeric excess was analyzed by HPLC equipped with
a Chiracel OJ-H column. Eluent¼n-heptane. Flow rate¼0.5 mL/
min; UV detector¼220 nm; retention times: tR¼50.65 min (S) and
54.90 min (R).
4.3.3. Benzyl-[1-(4-ﬂuorophenyl)ethyl]selane (6). Yellow oil (43%),
1H NMR (200 MHz, CDCl3): d 1.64 (d, J¼7.2 Hz, 3H), 3.69 (s, 2H), 3.80
(q, J¼7.2 Hz, 1H), 6.9e7.2 (m, 9H). 13C NMR (50 MHz, CDCl3): d 22.9,
37.6, 52.87, 114.9, 115.3, 115.3, 128.4, 128.4, 128.5, 128.7, 161.4 (d,
J¼243 Hz). LRMS (EI) m/z (%): 294 (Mþ, 4), 124 (7), 123 (100), 122
(7), 103 (20), 91 (22), 77 (5), 65 (6), 51 (3). FT-IR (ﬁlm, cm1) nmax:
2965, 2919, 1655, 1603, 1508, 1222, 1028, 834. [a]D22 þ84 (c 1.0,
CH2Cl2) for (S)-enantiomer (ee>99%) and [a]D22 100 (c¼1.0,
CH2Cl2) for (R)-enantiomer (ee>99%).
The enantiomeric excess was analyzed by HPLC equipped with
a Chiracel OJ-H column. Eluent¼mixture of n-heptane and iso-
propanol (99:1). Flow rate¼0.5 mL/min; UV detector¼220 nm; re-
tention times: tR¼27.28 min (S) and 31.62 min (R).
4.4. General procedure for selenium oxidation reactions me-
diated by BVMOs
To a ﬂask (2 mL, Eppendorf tube) containing the solution of the
racemic selenide compounds 1e6 (1 M in DMSO, 5 mL) were added
Tris/HCl buffer at pH 7.5 (50 mM, 440 mL), phosphite solution
(500 mM, 20 or 50 mL), NADPH (100 mM, 10 mL), PTDH (100 mM,
5 mL), and BVMO (100 mM, 20 or 40 mL). Reaction mixture was
shaken at 200 rpm and 30 C (PAMO and M446G PAMOmutant) or
150 rpm and 25 C (HAPMO and CHMO) for the appropriate time
(Table 1). The reaction mixture was extracted with EtOAc
(30.5 mL) and the organic extract was dried over Na2SO4 and
analyzed by HPLC. Control experiments in absence of enzyme were
performed for all substrates, and no selenium oxidation was
observed.
4.5. General procedure for selenium oxidation mediated by A.
terreus URM 3571 and CCT 3320
Erlenmeyer ﬂasks (250 mL) containing 100 mL of culture me-
dium (malt extract, 20 g/L) were inoculated with Aspergillus spores.
Growthwas carried out in an orbital shaker (160 rpm) at 32 C for 5
days. The fungal cells were harvested by ﬁltration.
The biotransformation was performed by re-suspending the
fungal cells (1 g) with Tris/HCl (50 mM, pH 7.5, 50 mL) in an
Erlenmeyer ﬂask (125 mL). To this cell suspension, selenide 1
(0.1 mmol) was added and incubated in an orbital shaker (160 rpm)
at 32 C for 1e5 days. Then reaction mixture was ﬁltered and the
aqueous layer was extracted with ethyl acetate (220 mL). The
organic extract was dried over Na2SO4 and analyzed by chiral HPLC.
Control experiments in absence of fungi were performed.
4.6. General procedure for selenium oxidation reactions me-
diated by CAL-B
To a ﬂask (2 mL, Eppendorf tube) containing the selenide 1
(0.25 mmol, 65 mg) were added the organic solvent (1 mL) and
CAL-B (20 mg). After 5 min, the oxidant (2 or 3 equiv, 0.5 or
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0.75 mmol) was added. Reaction mixture was shaken at room
temperature or 0 C for the appropriate time (Table 2). The enzyme
was ﬁltered and the solution was washed with distilled water and
the aqueous layer was extracted with n-hexane (21 mL). The or-
ganic extract was dried over Na2SO4 and analyzed by HPLC. Control
experiments in absence of enzyme and/or oxidant were performed.
Supplementary data
Supplementary data associated with this article can be found in
the online version, at http://dx.doi.org/10.1016/j.tet.2012.09.087.
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